BridgeBio Pharma (NASDAQ:BBIO) Earnings Information
BridgeBio Pharma last issued its quarterly earnings data on February 24th, 2021. The reported ($1.01) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.86) by $0.15. The firm had revenue of $0.12 million for the quarter, compared to analysts' expectations of $15.34 million. BridgeBio Pharma has generated ($2.48) earnings per share over the last year. BridgeBio Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 12th, 2021 based off prior year's report dates.
BridgeBio Pharma Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
BridgeBio Pharma (NASDAQ:BBIO) Earnings Estimates
2021 EPS Consensus Estimate: ($3.38)
BridgeBio Pharma (NASDAQ BBIO) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)